You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 20, November 13, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System, Other
 •Substance Abuse/ Alcoholism
 •Cardiovascular System
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS & OPINIONS
QTc Prolongation Among Hospitalized Patients Receiving Methadone

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with interest the study by Ehret and colleagues1 suggesting that clinically significant QTc interval prolongation (>500 milliseconds) occurred in over 16% of hospitalized patients receiving methadone. In practice, this probably overestimates the expected frequency of QTc prolongation with methadone use, given the authors’ exclusion criteria, but nonetheless suggests that considerable QTc prolongation with methadone use is probably not a rare phenomena.

The authors observed a modest correlation between methadone dose and the absolute QTc interval (r = +0.2; P<.01). Although they suggest that a dose-dependent effect of methadone has not been previously described in the hospital setting, we found a similar correlation between methadone dose and QTc among methadone-treated patients hospitalized with TdP (r = +0.51; P = .03).2 Variation in the strength of this correlation may be related to the fact that only 3.6% of the cohort in the study by Ehret et al1 experienced documented TdP . . . [Full Text of this Article]


AUTHOR INFORMATION
John Schmittner, MD; Mori J. Krantz, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Drug-Induced Long QT Syndrome in Injection Drug Users Receiving Methadone: High Frequency in Hospitalized Patients and Risk Factors
Georg B. Ehret, Cathy Voide, Marianne Gex-Fabry, Jocelyne Chabert, Dipen Shah, Barbara Broers, Valérie Piguet, Thierry Musset, Jean-Michel Gaspoz, Arnaud Perrier, Pierre Dayer, and Jules A. Desmeules
Arch Intern Med. 2006;166(12):1280-1287.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Mori J. Krantz and Philip S. Mehler
Arch Intern Med. 2004;164(3):277-288.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.